ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Inovalon Recognizes Innovators Driving Healthcare Excellence with the 2024 Impact Awards

BOWIE, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced the winners of the 2024 Inovalon Impact Awards, which celebrate the efforts of individuals and teams driving meaningful change and improving patient outcomes across the healthcare landscape. Announced at Empower, Inovalon’s annual data-driven summit, this year’s recipients were recognized for their outstanding contributions in innovation, data excellence, and collective teamwork in healthcare.

The awards feature three categories – Data Dream Team, Collective Excellence, and Innovator of the Year – each recognizing specific contributions to data-driven healthcare innovation. Winners receive a charitable donation in their name, amplifying the awards’ impact beyond the industry.

Data Dream Team

The Data Dream Team Award recognizes a team’s innovative, data-driven achievement that improves patient care, offers groundbreaking research insights, or enhances organizational performance.

Inovalon recognized the Health Care Service Corporation (HCSC) team for its effective collaboration in data collection and HEDIS® gap closure. The team converted information from an internal case management system into usable data for HEDIS measures. The team captured 395,110 new data points in the first run for the HEDIS engine, enabling the company to better serve the chronic care needs of its Medicare Advantage members.

“Data helps us focus our efforts to target outreach and improve the health of our members,” said Brandi Gustafik, Manager Quality Improvement at HCSC. “We believe we’re among the first insurers to find a way to overcome interoperability challenges in this way and very much appreciate being recognized for our efforts.”

Collective Excellence

The Collective Excellence Award recognizes healthcare organizations improving patient experiences and care outcomes. In response to the category receiving exceptional nomination stories, Inovalon named two recipients for their contributions: Walgreens and the Network Opioid Stewardship Committee at Inspira Health.

Walgreens was recognized for the launch and integration of Gene and Cell Services into its Specialty Pharmacy, investing in its capabilities as the company further grows its core pharmacy business to improve patient outcomes and provide greater value to payers and partners. Walgreens has established an 18,000-square-foot innovation center in Pittsburgh, PA, providing comprehensive support services for gene and cell emerging therapies.

Additionally, the Network Opioid Stewardship Committee at Inspira Health was recognized for collaborating with Inovalon’s Vigilanz solutions to close EHR data gaps, significantly enhancing the Pharmacy Surveillance and Opioid Module. Their efforts to optimize opioid prescribing practices and improve patient safety, aligning with SAMHSA grant goals.

Innovator of the Year

The Innovator of the Year Award celebrates a passionate healthcare professional pushing boundaries and ultimately driving impactful change in their respective line of work.

This year’s recipient is Karen Knight, Partner at Face Rock Enterprises. Knight was selected for her exceptional contributions to empowering Tribal health organizations through innovative financial strategies. By optimizing revenue cycle management, she helped one tribe generate over $500,000 in additional funds in just six months. Knight’s extensive experience in healthcare management and dedication to improving health outcomes in Tribal communities exemplifies her innovative approach to building sustainable healthcare systems.

“It is such an honor and blessing to be recognized for Innovator of the Year from Inovalon,” said Karen Knight of Face Rock Enterprises. “I work with Tribes all over the country and through ideas, thinking outside the box, and technical innovations, we are seeing profitability increase and improvement in healthcare outcomes. Together with Inovalon we are able to make innovation possible and tackle difficult problems.”

“We’re thrilled to recognize all of this year’s outstanding winners for their remarkable achievements and dedication to advancing healthcare innovation for the benefit of patients,” said Eron Kelly, President of Inovalon. “The 2024 Impact Awards recipients are truly driving meaningful change and improving patient outcomes, and we’re honored to celebrate their collective contributions to using data to drive innovation and transform healthcare.”

For more information, visit https://www.inovalon.com/awards or contact awards@inovalon.com.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). NCQA Measure Certification Program™ is a trademark of the National Committee for Quality Assurance (NCQA).  

About Inovalon        

Inovalon is a leading provider of cloud-based SaaS solutions empowering data-driven healthcare. The Inovalon ONE® Platform brings together national-scale connectivity, real-time primary source data access, and advanced analytics into a sophisticated cloud-based platform empowering improved outcomes and economics across the healthcare ecosystem. The company’s analytics and capabilities are used by nearly 20,000 customers supporting more than 53,000 sites of care, and are informed by the primary source data of more than 85 billion medical events across 1.1 million physicians, 677,000 clinical settings, and 395 million unique lives. For more information, visit www.inovalon.com.

Contact:
Tom Paolella
Sr. Director, Press and Analyst Relations, Inovalon
Thomas.Paolella@inovalon.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.